GlassScriptPhysician profile
Anil Akoon
NPI 1659791689
$12,342.02
in general payments reported to CMS, 2019-2025
14 companies · $751 in 2025
The $751 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,516 · 2020: $373 · 2021: $2,715 · 2022: $6,179 · 2023: $211 · 2024: $598 · 2025: $751.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,559.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,559.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novus Surgical Solutions LLC | $8,400.00 | 2021-2022 | |
| Rock Medical Orthopedics, INC. | $1,292.00 | 2019 | |
| Stryker Corporation | $642.77 | 2021-2025 | Gamma, Mako, Variax |
| Depuy Synthes Sales INC. | $414.39 | 2024-2025 | Na, Motoband |
| Medacta USA, INC. | $295.14 | 2021-2024 | |
| Fx Shoulder Solutions, INC | $283.79 | 2020 | |
| Endo Pharmaceuticals INC. | $223.92 | 2019 | |
| Skeletal Dynamics INC | $174.66 | 2025 | Geminus, Ijs, Align |
| Smith+Nephew, INC. | $148.05 | 2021-2025 | Stravix Pl |
| Integra Lifesciences Corporation | $123.73 | 2024-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Axogen | $91.06 | 2025 | |
| Nuvasive, INC. | $88.82 | 2020 | |
| Trimed, INC. | $86.40 | 2024 | |
| Medical Device Business Services, INC. | $77.29 | 2024 | Inhance |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anil Akoon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.